- The study achieved its primary endpoint. HEPLISAV is being jointly developed by Dynavax and Merck for use in adults and in patients with end stage renal disease.
- The primary endpoint was the proportion of subjects who developed protective antibodies to hepatitis B after administration. In PHAST, 95.1% of subjects who received two doses of HEPLISAV (n=1,819) developed protective antibodies to hepatitis B when measured at 12 weeks versus 81.1% of subjects who received three doses of Engerix-B (n=608) when measured at 28 weeks.

Other headlines for [DVAX]

• DVAX 11/3/2008 08:00am
  Dynavax Technologies Reports Q3 -$0.14 v -$0.14e, R $8.9M v $9.4Me
  
• DVAX 10/22/2008 07:20am
  Dynavax Technologies Credit Suisse Cuts DVAX to Neutral from Outperform, price target: $1
  
• DVAX 10/22/2008 06:35am
  Dynavax Technologies Oppenheimer Cuts DVAX to Market Perform from Outperform
  
• DVAX 10/21/2008 05:26pm
  Dynavax Technologies FDA advises Merck and DVAX that the balance of risk versus benefit no longer favors continuing HEPLISAV trial- The FDA has also advised the companies that there may be potential for an acceptable more...
  

Healthcare sector headlines

• HOLX Today 09:12am
  Hologic, Inc. Price Target lowered to $22 from $24 at Lazard, maintains buy rating
  
• CORT Today 09:00am
  Corcept Therapeutics Incorpora Names Caroline Loewy as new CFO- Ms. Loewy most recently served as CFO of Poniard Pharmaceuticals, a publicly traded biopharmaceutical company, where she was a key driver of that company's corporate more...
  
• LHCG Today 08:57am
  LHC Group Guides FY09 EPS $1.90-2.00 v $1.93e, R $450M-$470M v $436.2Me
  
• NPSP Today 08:50am
  NPS Pharmaceuticals Inc. Update: Initiates Phase 3 'STEPS' Study to Confirm GATTEX Reduces Parenteral Nutrition Dependence in Short Bowel Syndrome- Patient enrollment has begun in a Phase 3 registrational study to confirm more...
  
• OCLS Today 08:48am
  Oculus Innovative Sciences Update: Signs development agreement with Bayer Taiwan for Microcyn tech in Taiwanese animal market- As part of the agreement, Bayer Taiwan Co. Ltd. will be responsible for securing Taiwanese more...